Last updated: March 11, 2025
Sponsor: Aswan University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Post-surgical Pain
Pain
Chronic Pain
Treatment
Femoral nerve block with0.25% bupivacaine guided by ultrasound.
Preoperative IV fentanyl 100microgram
PENG block with0.25% bupivacaine guided by ultrasound.
Clinical Study ID
NCT06537323
Aswu 918/5/24
Ages 55-69 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- The included patient should be between 55 to 69 years
Exclusion
Exclusion Criteria:
- known allergies to local anesthetics
Study Design
Total Participants: 210
Treatment Group(s): 3
Primary Treatment: Femoral nerve block with0.25% bupivacaine guided by ultrasound.
Phase:
Study Start date:
June 01, 2024
Estimated Completion Date:
March 10, 2025
Study Description
Connect with a study center
Zaher
Cairo,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.